Betablokkere kan gavne patienter med KOL og hjertesygdom

Publikation: Bidrag til tidsskriftTidsskriftartikelfagfællebedømt

Standard

Betablokkere kan gavne patienter med KOL og hjertesygdom. / Rasmussen, Daniel Bech; Lange, Peter; Thorsten Jensen, Magnus.

I: Ugeskrift for Laeger, Bind 178, Nr. 6, V02150184, 21.03.2016, s. 555-559.

Publikation: Bidrag til tidsskriftTidsskriftartikelfagfællebedømt

Harvard

Rasmussen, DB, Lange, P & Thorsten Jensen, M 2016, 'Betablokkere kan gavne patienter med KOL og hjertesygdom', Ugeskrift for Laeger, bind 178, nr. 6, V02150184, s. 555-559. <http://ugeskriftet.dk/videnskab/betablokkere-kan-gavne-patienter-med-kol-og-hjertesygdom>

APA

Rasmussen, D. B., Lange, P., & Thorsten Jensen, M. (2016). Betablokkere kan gavne patienter med KOL og hjertesygdom. Ugeskrift for Laeger, 178(6), 555-559. [V02150184]. http://ugeskriftet.dk/videnskab/betablokkere-kan-gavne-patienter-med-kol-og-hjertesygdom

Vancouver

Rasmussen DB, Lange P, Thorsten Jensen M. Betablokkere kan gavne patienter med KOL og hjertesygdom. Ugeskrift for Laeger. 2016 mar. 21;178(6):555-559. V02150184.

Author

Rasmussen, Daniel Bech ; Lange, Peter ; Thorsten Jensen, Magnus. / Betablokkere kan gavne patienter med KOL og hjertesygdom. I: Ugeskrift for Laeger. 2016 ; Bind 178, Nr. 6. s. 555-559.

Bibtex

@article{a81ea594907b4ab587c7a8eab499ca22,
title = "Betablokkere kan gavne patienter med KOL og hjertesygdom",
abstract = "Patients with chronic obstructive pulmonary disease and heart disease can benefit from beta-blocker treatmentChronic obstructive pulmonary disease (COPD) and coronary heart disease share smoking as the most important com­mon risk factor and there is a high prevalence of cardio­vascular disease among COPD patients. Although cardiose­lective beta-blockers are safe in treatment of COPD, they are often withheld in these patients. In observational studies, beta-blocker treatment is associated with significantly reduced mortality and reduced risk of exacerbations of COPD. This effect may be caused by the beneficial effect of beta-blockers on heart failure, tachycardia and upregulation of beta-receptors in the airways.",
author = "Rasmussen, {Daniel Bech} and Peter Lange and {Thorsten Jensen}, Magnus",
year = "2016",
month = mar,
day = "21",
language = "Dansk",
volume = "178",
pages = "555--559",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "6",

}

RIS

TY - JOUR

T1 - Betablokkere kan gavne patienter med KOL og hjertesygdom

AU - Rasmussen, Daniel Bech

AU - Lange, Peter

AU - Thorsten Jensen, Magnus

PY - 2016/3/21

Y1 - 2016/3/21

N2 - Patients with chronic obstructive pulmonary disease and heart disease can benefit from beta-blocker treatmentChronic obstructive pulmonary disease (COPD) and coronary heart disease share smoking as the most important com­mon risk factor and there is a high prevalence of cardio­vascular disease among COPD patients. Although cardiose­lective beta-blockers are safe in treatment of COPD, they are often withheld in these patients. In observational studies, beta-blocker treatment is associated with significantly reduced mortality and reduced risk of exacerbations of COPD. This effect may be caused by the beneficial effect of beta-blockers on heart failure, tachycardia and upregulation of beta-receptors in the airways.

AB - Patients with chronic obstructive pulmonary disease and heart disease can benefit from beta-blocker treatmentChronic obstructive pulmonary disease (COPD) and coronary heart disease share smoking as the most important com­mon risk factor and there is a high prevalence of cardio­vascular disease among COPD patients. Although cardiose­lective beta-blockers are safe in treatment of COPD, they are often withheld in these patients. In observational studies, beta-blocker treatment is associated with significantly reduced mortality and reduced risk of exacerbations of COPD. This effect may be caused by the beneficial effect of beta-blockers on heart failure, tachycardia and upregulation of beta-receptors in the airways.

M3 - Tidsskriftartikel

C2 - 26376419

VL - 178

SP - 555

EP - 559

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 6

M1 - V02150184

ER -

ID: 153787727